Brian Lian | executive |
Gregory Zante | executive |
Joon Lee | analyst |
Steven Seedhouse | analyst |
Jay Olson | analyst |
Nazibur Rahman | analyst |
Tsan-Yu Hsieh | analyst |
Thomas Smith | analyst |
Yale Jen | analyst |
Joseph Pantginis | analyst |
Justin Zelin | analyst |
Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, February 7, 2024. I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ahead.
Hello, and thank you all for participating in today's call.